New AstraZeneca drug to treat breast cancer 'shatters expectations'
Pharmaceutical company AstraZeneca said Enhertu showed a 72% reduction. Trial involved 500 patients at sites in Asia, Europe, Oceania and the Americas. But it was pointed out analysis 'not yet mature and is not statistically significant'.
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Breast cancer drug raises hopes of 'cure' after it STOPPED disease progressionA NEW drug designed to treat a form of breast cancer has been hailed as “groundbreaking” by top scientists – raising hopes of finding a cure. AstraZeneca said the trial of the medicine …
Lire la suite »
Breast cancer drug raises hopes of 'cure' after it STOPPED disease progressionA NEW drug designed to treat a form of breast cancer has been hailed as “groundbreaking” by top scientists – raising hopes of finding a cure. AstraZeneca said the trial of the medicine …
Lire la suite »
New drug could slow tumour regrowth in inoperable bowel cancerAdavosertib found to delay tumour growth in some patients in clinical trial, with few side effects
Lire la suite »
Captain Tom ‘would have loved’ new book One Hundred Reasons To Hope
Lire la suite »
Sister of fiancé of woman missing travelling in US insists family want her foundIn a new interview Cassie Laundrie said the missing Gabby Petito is 'like a sister' and she hopes the case will turn out to be just 'a big misunderstanding'
Lire la suite »
Rugby legend in race against time to get MND wonder drug to see kids grow upEx Leeds Rhinos star Rob Burrow hopes a groundbreaking treatment could buy him enough time for a cure to be found for Motor Neuron Disease which has put him in a wheelchair
Lire la suite »